These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1287745)

  • 21. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Infection by HTLV-1 in heroin addicts in Barcelona].
    Soriano V; Tor J; Ribera A; Muga R
    Med Clin (Barc); 1989 May; 92(20):799. PubMed ID: 2796428
    [No Abstract]   [Full Text] [Related]  

  • 23. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Death due to drug addiction in Ile-de-France].
    Lecomte D; Hatton F; Michel E; Le Toullec A; Jougla E
    Rev Epidemiol Sante Publique; 1995 Dec; 43(6):560-72. PubMed ID: 8552854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
    Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
    Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the liberalization of syringe sales on the behaviour of intravenous drug users in France.
    Ingold FR; Ingold S
    Bull Narc; 1989; 41(1-2):67-81. PubMed ID: 2765721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trend of mortality observed in a cohort of drug addicts of the metropolitan area of Bologna, North-Eastern Italy, during a 25-year-period.
    Manfredi R; Sabbatani S; Agostini D
    Coll Antropol; 2006 Sep; 30(3):479-88. PubMed ID: 17058511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for controlled heroin use? Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland).
    Shewan D; Dalgarno P
    Br J Health Psychol; 2005 Feb; 10(Pt 1):33-48. PubMed ID: 15826332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping heroin careers: utilising a standardised history-taking method to assess the speed of escalation of heroin using careers in a treatment-seeking cohort.
    Best D; Day E; Cantillano V; Gaston RL; Nambamali A; Sweeting R; Keaney F
    Drug Alcohol Rev; 2008 Mar; 27(2):165-70. PubMed ID: 18264877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of drug abuse and prevalence of antibodies to human immunodeficiency virus in heroin addicts in Jerusalem, 1989.
    Shufman EN; Engelhard D; Bar-El CY; Morag A
    Isr J Med Sci; 1990 Nov; 26(11):616-8. PubMed ID: 2254077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection among heroin users and area of residence.
    Long J; Keenan E; Grogan L; Mullen L; Barry J; Sinclair H
    Ir Med J; 2006 Sep; 99(8):230-3. PubMed ID: 17120604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Somatic symptoms in opiate abuse].
    Quadri F; Russi E
    Schweiz Med Wochenschr; 1985 Feb; 115(7):226-34. PubMed ID: 3885385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the heroin epidemic, its impact, its context, and health policy].
    Villalbí JR; Brugal MT
    Med Clin (Barc); 1999 May; 112(19):736-7. PubMed ID: 10394572
    [No Abstract]   [Full Text] [Related]  

  • 39. [4-month follow-up of 198 heroin addicts by general practitioners].
    Charpak Y; Nory-Guillou F; Blin P; Monaque C
    Rev Epidemiol Sante Publique; 1997 Mar; 45(1):13-22. PubMed ID: 9173454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.